Literature DB >> 6296232

alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes.

M A Rodriguez, W A Prinz, W L Sibbitt, A D Bankhurst, R C Williams.   

Abstract

Interferons (IFN) are known to modulate immune responses in either an inhibitory or a stimulating manner. The present study was initiated to investigate the mechanisms by which alpha-IFN modulates Ig production of human peripheral blood mononuclear cells (PBMC). IgG and IgM production was measured in pokeweed mitogen- (PWM) stimulated 7-day cultures of PBMC. Significant enhancement of IgM and IgG production was observed when alpha-IFN was added. Overnight preincubation followed by washing also produced significant enhancement. The effect of alpha-IFN was not obtained in the absence of PWM or T cells. The effect of alpha-IFN on cultures of B and T cells was not altered by irradiation of T cells (2000 rad). alpha-IFN was not shown to enhance the production of helper factor but did increase the responsiveness of B cells to helper factor if the B cells were preincubated with alpha-IFN. Finally, alpha-IFN did not increase the Ig production of PBMC induced by Epstein Barr virus (EBV), and the outgrowth of EBV-infected PBMC was not affected. Overall, these results show for the first time that the effect of alpha-IFN on PBMC is due to an enhanced responsiveness of B cells to helper factors produced by radioresistant T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296232

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis.

Authors:  M A Rodriguez; I Blanca; M L Baroja; S Arama; M Leon-Ponte; I Abadi; N E Bianco
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

3.  Enhanced antibody responses in mice by combined administration of interferon with rabies vaccine.

Authors:  K Mifune; K Mannen; S Cho; H Narahara
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease.

Authors:  M A Rodriguez; J D Montano; R C Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  Lymphocyte-reactive antibodies in acquired immune deficiency syndrome.

Authors:  R C Williams; H Masur; T J Spira
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

6.  Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.

Authors:  Dhohyung Kim; Luis Martinez-Sobrido; Changsun Choi; Natasha Petroff; Adolfo García-Sastre; Stefan Niewiesk; Thomas Carsillo
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

Review 7.  Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.

Authors:  A Faro
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester.

Authors:  T H Tötterman; M Carlsson; K Nilsson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

10.  Interactions of IgG from SLE patients with peripheral blood mononuclear cells and adherent cell populations.

Authors:  F Ramirez; R B Searles; R C Williams
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.